Back to Search

MAX RUBENSTEIN, DO

DO

Psychiatry Physician

NPI: 1417585159IndividualAccepts Medicare

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Psychiatry PhysicianPrimary

Psychiatry & Neurology — Psychiatry

Code: 2084P0800X

67693(CO)

CMS Specialties

PrimaryPSYCHIATRY

Education

NOVA SOUTHEASTERN COLLEGE OF OSTEO MEDICINE

Class of 2020

Research & Publications (20)

Regenerative patterning in Swarm Robots: mutual benefits of research in robotics and stem cell biology.
PMID 19557691·Int J Dev Biol·2009
7-preclinical
Cutaneous Rosai-Dorfman disease.
PMID 16638376·Dermatol Online J·2006
5-case
Cutaneous manifestations of Hodgkin's disease.
PMID 16533224·Int J Dermatol·2006
8-other
Persistent cutaneous manifestations of hyperoxaluria after combined hepatorenal transplantation.
PMID 15347492·Dermatol Online J·2004
5-case
Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2.
PMID 19533419·Med Oncol·2010
8-other
Multigene targeting of signal transduction pathways for the treatment of breast and prostate tumors: comparison between combination therapies employing bispecific oligonucleotides with either Rapamycin or Paclitaxel.
PMID 18686047·Med Oncol·2009
4-observational
Do intra-tumor alkaline micro-regions represent additional therapeutically privileged sites?
PMID 18364249·Med Hypotheses·2008
7-preclinical
Treatment of MCF-7 breast cancer cells employing mono- and bispecific antisense oligonucleotides having binding specificity toward proteins associated with autocrine regulated growth and BCL-2.
PMID 17972023·Med Oncol·2008
8-other
Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease.
PMID 17879274·Inflamm Bowel Dis·2008
8-other
Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors.
PMID 17917084·Med Oncol·2007
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
791 Chambers Rd
Aurora, CO 80011

Locations (2)

Practice Location

791 Chambers Rd, Aurora, CO
(803) 617-2300

Practice Location

700 POTOMAC ST, AURORA, CO
(720) 282-8015

Quick Facts

NPI
1417585159
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
6
Publications
20

Are you this provider?

Claim Your Profile